Birdwatch Note
2023-07-24 11:37:08 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
On 22 April 2022, following publication of new data from a clinical trial looking at the outcome of admission to hospital, WHO now suggests the use of remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization. https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients
Written by 2C1074C7E444187674141595B8261032095E7415BD3DA56A06E1A0E733C82EE8
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1683199649807572992
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1683441180124536832
- noteId - 1683441180124536832
- participantId -
- noteAuthorParticipantId - 2C1074C7E444187674141595B8261032095E7415BD3DA56A06E1A0E733C82EE8 Participant Details
- createdAtMillis - 1690198628822
- tweetId - 1683199649807572992
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- On 22 April 2022, following publication of new data from a clinical trial looking at the outcome of admission to hospital, WHO now suggests the use of remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization. https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-07-24 11:37:08 UTC (1690198628822) |
1969-12-31 23:59:59 UTC (-1) |
2023-07-25 02:10:02 UTC (1690251002506) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-07-24 14:43:31 -0500 | Rating Details | |
2023-07-24 14:40:08 -0500 | Rating Details | |
2023-07-24 10:15:30 -0500 | Rating Details | |
2023-07-24 09:23:21 -0500 | Rating Details | |
2023-07-24 08:59:23 -0500 | Rating Details | |
2023-07-24 07:16:29 -0500 | Rating Details | |
2023-07-24 06:50:07 -0500 | Rating Details |